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ABSTRACT
Collagen IV is a major component of basement membranes, and
mutations in COL4A1, which encodes collagen IV alpha chain 1,
cause a multisystemic disease encompassing cerebrovascular, eye
and kidney defects. However, COL4A1 renal disease remains
poorly characterized and its pathomolecular mechanisms are
unknown. We show that Col4a1 mutations in mice cause
hypotension and renal disease, including proteinuria and defects
in Bowman’s capsule and the glomerular basement membrane,
indicating a role for Col4a1 in glomerular filtration. Impaired sodium
reabsorption in the loop of Henle and distal nephron despite
elevated aldosterone levels indicates that tubular defects contribute
to the hypotension, highlighting a novel role for the basement
membrane in vascular homeostasis by modulation of the tubular
response to aldosterone. Col4a1 mutations also cause diabetes
insipidus, whereby the tubular defects lead to polyuria associated
with medullary atrophy and a subsequent reduction in the ability to
upregulate aquaporin 2 and concentrate urine. Moreover,
haematuria, haemorrhage and vascular basement membrane
defects confirm an important vascular component. Interestingly,
although structural and compositional basement membrane defects
occurred in the glomerulus and Bowman’s capsule, no tubular
basement membrane defects were detected. By contrast, medullary
atrophy was associated with chronic ER stress, providing evidence
for cell-type-dependent molecular mechanisms of Col4a1
mutations. These data show that both basement membrane
defects and ER stress contribute to Col4a1 renal disease, which
has important implications for the development of treatment
strategies for collagenopathies.
KEY WORDS: Collagen IV, Extracellular matrix, Endoplasmic
reticulum stress, Basement membrane, Kidney disease
INTRODUCTION
Collagen IV is a major component of the basement membrane
(BM), a specialised extracellular matrix structure that provides
structural support and influences cell behaviour and signalling.
Vertebrates express six collagen IV alpha chains, Col4a1-Col4a6,
and in the endoplasmic reticulum (ER) three alpha chains form
triple-helical protomers that generate three collagen IV networks:
α1α1α2(IV), α3α4α5(IV) and α5α5α6(IV) (Khoshnoodi et al.,
2008; Van Agtmael and Bruckner-Tuderman, 2010). During
kidney development, all BMs contain α1α1α2(IV), whereas in
adult kidney it is mainly expressed in vascular, Bowman’s
capsule, mesangial and tubular BMs (Hudson et al., 2003). The
adult glomerular BM (GBM) predominantly contains α3α4α5
(IV), and mutations affecting this network cause Alport syndrome
(Hudson et al., 2003).
We have previously identified mouse models with Col4a1
mutations: Col4a1+/Raw and Col4a1+/Svc, containing a lysine
(K950E) and a glycine substitution (G1064D), respectively (Van
Agtmael et al., 2005). Initial histopathological analysis on a mixed
genetic background indicated that within this allelic series the
glycine mutations appear to cause a more severe phenotype (Van
Agtmael et al., 2005).Col4a1mousemodels are excellent models of
the human disease, illustrated by the fact that their analysis led to the
identification of humans with COL4A1/COL4A2 mutations (Favor
et al., 2007; Gould et al., 2005; Jeanne et al., 2012; Murray et al.,
2014; Sibon et al., 2007; Yoneda et al., 2012). Mutations in
COL4A1 and COL4A2 cause a multisystemic disorder that leads to
cerebrovascular disease, eye defects and muscular dystrophy
(Vahedi and Alamowitch, 2011). Some patients present with
HANAC (hereditary angiopathy, nephropathy, aneurysms and
cramps) syndrome and can develop haematuria, Bowman’s
capsule defects, large renal cysts and reduced glomerular filtration
rate (GFR; Plaisier et al., 2007). HANAC syndrome has been
proposed as a clinical sub-entity within COL4A1/COL4A2 disease
(Alamowitch et al., 2009), resulting from mutations located in or
close to the integrin-binding CB3 region of the collagen protomer
predicted to affect integrin signalling (Plaisier et al., 2010).
Importantly, COL4A1/COL4A2 variants have also been implicated
in sporadic cases of cerebral vascular disease in the general
population (Rannikmae et al., 2015; Weng et al., 2012).
COL4A1/COL4A2 mutations are associated with BM defects,
ER stress and the unfolded protein response (UPR; Gould et al.,
2007; Murray et al., 2014; Van Agtmael et al., 2010). ER stress
can be induced by the accumulation of misfolded protein within
the ER, and the UPR aims to relieve ER stress by reducing general
protein synthesis and increasing the levels of chaperones to
promote protein folding (Bateman et al., 2009). Although the UPRReceived 31 May 2015; Accepted 24 November 2015
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is a homeostatic response, chronic ER stress activates pro-
apoptotic pathways, in part mediated via activation of the
protein CHOP (C/EBP homologous protein; Ron and Walter,
2007), and can become pathogenic. Chronic ER stress has recently
been implicated in a variety of matrix diseases (Bateman et al.,
2009) in addition to kidney diseases such as uromodulin-
associated kidney disease (Williams et al., 2009) and Pierson
syndrome, caused by mutations in the basement membrane
component laminin beta 2 (Chen et al., 2013).
Our initial analysis in Col4a1 mutant mice revealed a renal
component in Col4a1 disease mainly affecting Bowman’s capsule
(Van Agtmael et al., 2005), whereas analysis of other mouse models
indicated mild proteinuria (Favor et al., 2007). Individuals with
HANAC syndrome develop similar defects in Bowman’s capsule
and also a structural phenotype to the tubular BM and the formation
of large cysts (Plaisier et al., 2007), although they do not develop a
polycystic kidney disease (Plaisier et al., 2010, 2007). However, the
role of this essential BM component in renal pathophysiology
remains relatively poorly characterized; for example, the potential
progression of Col4a1 renal disease and its pathomolecular
mechanisms are unknown.
Here, we have uncovered that Col4a1 mutations in mice cause
renal glomerular and tubular disease, which becomes more severe
with age and leads to proteinuria, polyuria and haematuria. Our data
support the suggestion that Col4a1 mutations can display
cell-specific pathomolecular mechanisms, because the glomerular
and tubular disease components are associated with BM defects and
ER-stress-induced apoptosis, respectively. This has important
implications for the development of therapeutic approaches.
RESULTS
Col4a1 renal disease includes renal and tubular disease that
develops with age
We assessed in vivo renal function in 3- to 4-month-oldCol4a1+/Raw
(Fig. 1; Table 1) and Col4a1+/Svc (Table 1; Fig. S1) mice,
which revealed a reduction in blood pressure of ∼20 mmHg
(Fig. 1A; Fig. S1A). Col4a1+/Raw mice display reduced Na+
excretion (Fig. 1B) and GFR as assessed by in vivo inulin clearance
assays (Fig. 1C; Table 1). Col4a1 mutant mice have an activated
renin-angiotensin system, as indicated by elevated aldosterone
levels (Table S1; Van Agtmael et al., 2010). We used diuretic
profiling to determine the in vivo activity of the major aldosterone-
sensitive sodium transport proteins in Col4a1+/Raw mice (Fig. 1D),
whereby responses to furosemide, thiazide and amiloride were
measured to assess in vivo activity of the Na+-K+-2Cl−
cotransporter (NKCC2), the Na+-Cl− cotransporter (NCC) and
the epithelial sodium channel (ENaC), respectively (Bailey et al.,
2009; Hunter et al., 2014, 2015). Furosemide-sensitive sodium
reabsorption was ∼3.5-fold reduced in Col4a1 mutant mice, but
this was a functional downregulation of NKCC2 activity because
total protein levels were similar to WT (WT) mice (Fig. S2).
Likewise, thiazide-sensitive sodium reabsorption in Col4a1
mutant mice was approximately fourfold reduced, indicating
downregulation of NCC. Amiloride-sensitive sodium reabsorption
Fig. 1. Analysis of renal function.
(A-D) In vivo renal function analysis
of 1-, 3- to 4- and 6- to 8-month-old
Col4a1+/Raw (black bars) and WT (white
bars) mice. (A) Reduced mean arterial
blood pressure in Col4a1+/Raw animals
at all ages. (B) Reduced sodium
excretion in Col4a1+/Raw animals at all
ages. (C) Inulin clearance assays
uncovered reduced glomerular filtration
rate per gram body weight at 3 months
(∼40% reduction), but no further decline
with age. (D) Measurement of sodium
excretion in the presence of the diuretics
furosemide and thiazide remains
reduced in mutant animals. Blockade of
ENaC by amiloride abolished the
difference between WT and mutant
mice. (E) Western blotting showed
∼16-fold increased levels of total NHE3
(NHE3) in Col4a1+/Svc (SVC) mice but
unaltered phosphorylated NHE3
(p-NHE3). Representative band of total
protein stain is given as loading control
(entire gel is provided in Fig. S6).
(F) ImageJ densitometry analysis of
total and p-NHE3. *P<0.05, **P<0.01,
***P<0.001. n=5-7 in A-E; n=3-5 in F.
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via ENaC was comparable to WT (Fig. 1D), despite the elevated
aldosterone levels. The net increase in tubular sodium reabsorption
could be explained by the ∼16-fold increased protein levels of
active unphosphorylated sodium hydrogen exchanger (NHE3;
Fig. 1E,F).
These data indicate that the reduced blood pressure leads
to increased sodium reabsorption and activation of the
renin-angiotensin-aldosterone system (RAAS) as an attempt to
normalize blood pressure. However, the response to the diuretics
revealed that Col4a1 mutant mice have aldosterone insensitivity of
the distal nephron, thereby reducing the efficacy of the RAAS to
increase blood pressure levels, a factor that could contribute to the
development of low blood pressure. To compensate for this deficit,
mutant mice activate reabsorption in the proximal tubule via NHE3.
A reduction in GFR would reduce the filtered sodium load and also
help to preserve sodium homeostasis. However, low GFR was not a
consistent feature across the age groups; 1-month-old Col4a1+/Raw
animals revealed a normal GFR and increased sodium reabsorption
(Fig. 1B,C; Table S1). We also failed to detect a decline in GFR in
6- to 8-month-old mice (Fig. 1C; Table S2). This absence of a
further decline in GFR indicates that COL4A1 renal disease is
unlikely to progress to renal failure, which is supported by a limited
reduction of GFR in humans with HANAC syndrome (Plaisier et al.,
2007).
Diabetes insipidus resulting from Col4a1mutations
Polyuria and polydipsia are hallmarks of diabetes insipidus that
could be attributable to reduced vasopressin production in the brain
(central diabetes insipidus) or inability of the kidney to concentrate
urine in response to vasopressin (nephrogenic diabetes insipidus;
Babey et al., 2011). Despite the low blood pressure and increased
sodium reabsorption, a metabolic cage study revealed polyuria in
mutant animals, with Col4a1+/Raw mice displaying a ∼1.8-fold
increase in daily urine production (Fig. 2A) and a∼1.7-fold increase
in urine flow rate as measured by in vivo renal clearance assays
(Fig. 2B), further confirming the tubular disease. Data from
Col4a1+/Svc mice confirmed this (Fig. 2C,D; Table 1; Fig. S1).
The polyuria is accompanied by a twofold increase in water
consumption (polydipsia; Fig. 2D) and reduced urine osmolality
(Fig. 2E; Fig. S1), indicating a defect in concentrating urine that
occurs in the distal tubules. Analysis of 1-month-old Col4a1+/Raw
animals revealed normal water excretion and urine osmolality
(Fig. 2E; Tables S1 and S2). However, there is a further decline in
urine osmolality at 6-8 months, indicating that polyuria becomes
more severe with age. Polyuria (∼4.7-fold increase; Fig. 2F) and
polydipsia (∼1.6-fold increase; Fig. S1E) were also observed in 2.5-
month-old Col4a1+/Svc mice.
To investigate whether primary polydipsia (increased thirst)
causes the apparent diabetes insipidus, mice were deprived of water
for 24 h. Although there was an approximately twofold reduction in
daily urine output in mutant mice, compared with approximately
threefold in controls (Fig. 2G), it remained significantly higher in
Col4a1+/Svcmice. This revealed that mutant mice partly retained the
ability to concentrate their urine and excludes primary polydipsia as
being causative. Mutant mice had increased weight loss when
deprived of water, which became more severe with age (Fig. 2H),
indicating dehydration, which combined with the elevated urine
output during water deprivation (Fig. 2I), further supports the
presence of diabetes insipidus. To distinguish between nephrogenic
and central diabetes insipidus, urine output was measured following
injection (1 µg/kg) with arginine vasopressin (Gabbi et al., 2012).
Overall, 4- to 5-month-old mutant mice maintained an elevated
urine output, demonstrating a reduced ability of mutant kidneys to
respond to vasopression and thus nephrogenic diabetes insipidus
(Fig. 2I). However, a dichotomy was observed, because some
mutant mice, which were polyuric, responded to vasopressin,
suggesting a component of central diabetes insipidus. Analysis of
2.5-month-old mice revealed increased urine output when deprived
of water (Fig. S1F). In accordance with nephrogenic diabetes
insipidus, untreated 4-month-old Col4a1 mutant mice did not have
elevated levels of the water channel aquaporin 2 (Aqp2; Fig. 2J) that
plays a crucial role in tubular water reabsorption and urine
concentration. The variability observed in Aqp2 expression,
supported by the vasopressin data, could reflect differing severity
of the phenotype, as is characteristic for Col4a1 mutant mice and
patients (Vahedi and Alamowitch, 2011; Van Agtmael et al., 2005),
and/or variation in the onset and progression of the defects (see
below). Thus, inability to increase Aqp2 expression is in keeping
with a generalised homeostatic failure of the distal nephron and, in
Col4a1 mutant mice, leads to a failure to concentrate urine and
diabetes insipidus.
Erythropoietin treatment rescues the hypotension
Col4a1 mutant mice display reduced blood volume and haematocrit
levels but normal plasma volume (Van Agtmael et al., 2010), and
recently, anaemia has been described in individuals with a COL4A1
mutation (Tomotaki et al., 2014; Yoneda et al., 2013). The
mechanism underlying the reduced red blood cell number remained
unexplored, but a defect in erythropoiesis or erythrocyte maturation
could be a contributing factorwhereby the kidney disease affects renal
erythropoietin production. To determine whether the reduced
haematocrit in Col4a1 mutant mice can be explained by reduced
erythrocyte maturation, Col4a1+/Svc mice were treated with human
recombinant erythropoietin (Epo) for 2 weeks. Interestingly, Epo
Table 1. Renal defects in 3- to 4-month-old female Col4a1+/Raw and Col4a1+/Svc mice
Parameter Wild type Col4a1+/Raw Col4a1+/Svc
Body weight (g) 20.4±0.7 21.2±0.5 19.3±0.3**
Mean arterial blood pressure (mmHg) 97.12±2.2 79.20±1*** 73.16±4.14**
Glomerular filtration rate (ml/min) 0.27±0.014 0.15±0.013** 0.19±0.003**
Glomerular filtration rate (ml/min/100 g body weight) 0.896±0.07 0.509±0.06** 0.817±0.02
Na+ excretion (µmol/min) 0.27±0.05 0.07±0.01** 0.088±0.016**
Plasma Na+ (mmol/l) 148.6±2.2 147.4±1.1** 149.6±1.4
K+ excretion (µmol/min) 0.37±0.06 0.38±0.06 NM
Plasma osmolality (mOsm/kg H2O) 331±5.78 352±3.11** 341±4.18
Urine osmolality (mOsm/kg H2O) 1946±255 923±99** 926±72**
Haematocrit (%) 45±0.1 36.6±0.7*** 39.5±0.3***
*P<0.05, **P<0.01, ***P<0.001measuredby two-wayANOVAwithBonferroni post hoc test andStudent’sunpaired t-test asappropriate.NM,notmeasured.n=5-7.
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treatment rescued haematocrit levels in 4-month-oldCol4a1+/Svcmice
(Fig. 3A) and the increased haematocrit levelswere associatedwith an
increased in blood pressure in Col4a1 mutant mice (Fig. 3B). These
data confirm that reduced renal Epo production and subsequent
erythrocyte maturation contribute to the haematological and blood
pressure phenotypes.
Age-dependent atrophy of the medulla and Bowman’s
capsule defects contribute to renal dysfunction
To determine any morphological basis to the renal dysfunction, we
performedHaematoxylin andEosin stainingon21- and40-day-old, 3-
to 4- and 6- to 8-month-old Col4a1+/Rawmice (Fig. 4A,B; Table S3).
This identified glomerulopathy characterized by hypertrophy and a
Fig. 2. Diabetes insipidus inCol4a1
mutant mice. (A) Metabolic cage
study revealed ∼1.8-fold increased
24 h (24H) urine production in
Col4a1+/Raw (RAW) mice per gram
body weight (g BW; n=6). (B) In vivo
urine flow was ∼1.7-fold increased in
3- to 4-month-old mice. Older mutant
mice displayed similar trends.
(n=4-6). (C) Metabolic cage study
revealed increased daily (24 h) urine
production in 4- to 5-month-old
Col4a1+/Svc (SVC) mice per gram
body weight (n=4-6). (D) Metabolic
cage study indicates ∼4.2-fold
increased daily water consumption
in Col4a1+/Svc mice (WT, n=6;
Col4a1+/Svc, n=10). (E) Col4a1+/Raw
mice develop a reduced urine
osmolality at 3 months, which
becomesmore severewith age. Urine
osmolality of 3- to 4-month-old
Col4a1+/Svc mice is provided in Fig.
S1D (n=5-7). (F) Increased urine
production in 2.5-month-old
Col4a1+/Svc mice compared with
controls (n=3). (G) Effect of water
deprivation (WD) on urine production
in wild-type and Col4a1+/Svc mice
(n=4-5). (H) Percentage weight loss
following 24 h water deprivation in
2.5- (2.5M) and 4- to 5-month-old
animals (2.5M, n=3; 4-5 months old,
n=4-5). (I) Urine production after
vasopressin injection. (J) Analysis of
Aqp2 protein levels in 4- to 6-month-
old Col4a1+/Svc mice. Representative
band of total protein stain is given as
loading control (entire gel is provided
in Fig. S6) (n=3) with densitometry
analysis using ImageJ. *P<0.05,
**P<0.01, ***P<0.001.
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more cuboidal appearance of the parietal epithelium of Bowman’s
capsule (Van Agtmael et al., 2005; Fig. 4A), which develops fully by
40 days of age (Table S3). No significant difference in cellularity of
the glomerulus or glomerulosclerosis was detected, confirming that
the glomerulopathy primarily affects Bowman’s capsule. The
morphological defects progress with age, because at around
3 months atrophy of the medulla begins to develop and becomes
fully penetrant by 6 months (Fig. 4B; Table S3). Hydronephrosis
might also contribute to the atrophy of the medulla, because mutant
animals develop distended bladders (data not shown). However,
mutant mice urinate freely as indicated by our metabolic cage studies,
excluding an obstruction in the urethra being the major cause. These
datawere confirmed in 40-day-old and 3- to 4-month-oldCol4a1+/Svc
mice (Fig. 4A,B and data not shown). The onset of atrophy of the
medulla corresponds with the increased urine flow rate, and further
reduced urine osmolality (Fig. 2E). This suggests that the medullary
atrophy is likely to prevent the ability to increase Aqp2 levels
sufficiently to concentrate the urine, resulting in a nephrogenic
component to the diabetes insipidus. Combinedwith the data showing
polyuria in 2.5-month-old animals (Fig. 2F), which is before the
medullary atrophy has developed, this provides evidence for the
development of an initial central diabetes insipidus with an additional
nephrogenic component as animals age.
To investigate the development of any fibrosis, we performed
PicroSirius Red staining and immunostaining against collagen
I. Although increased collagen I staining could occasionally be
observed in the perivascular tissue of some blood vessels in mutant
kidneys, this analysis failed to detect any signs of overt renal fibrosis
(Fig. S3A). Finally, absence of renal phenotypes in 3-month-old
Col4a1+/Raw mice on a mixed genetic background (Van Agtmael
et al., 2005) confirms that genetic modifiers influence Col4a1 renal
disease.
Col4a1mutant mice develop proteinuria and haematuria
Although Col4a1 is not major component of the GBM,
histopathological analysis of 3- to 4-month-old mice revealed
protein casts within tubules (Fig. 4C), suggesting the development
of proteinuria. This is supported by increased total protein levels in
Col4a1+/Raw and Col4a1+/Svc urine samples analysed by SDS-
PAGE (Fig. S4A). Enzyme-linked immunosorbent assay (ELISA)
analysis was performed to measure albumin-to-creatinine ratios of
urines samples, which revealed increased albumin-to-creatinine
ratios in mutant mice (Fig. S4B), confirming the development of
mild proteinuria and highlighting an under-recognised role for
α1α1α2(IV) in the filtration apparatus. Besides polyuria and
proteinuria, mice also develop haematuria (Fig. 4D,E), similar to
humans with HANAC syndrome (Plaisier et al., 2010, 2007), as
indicated by dipstick analysis of urine samples collected in
metabolic cage studies [Col4a1+/Svc (6/6) Col4a1+/Raw (1/8) and
wild-type (0/10); Fig. 4E]. Perls staining of kidney sections revealed
haem deposits in renal tissue (Fig. 4D), confirming that renal
haemorrhage underlies the haematuria and that vascular defects
contribute to renal pathophysiology.
Col4a1mutations affect BM structure and composition
To shed light on pathomolecular disease mechanisms, electron
microscopy was performed on 3- to 4-month-old mice, which
revealed structural BM defects predominantly in the BMs of
Bowman’s capsule and the vasculature (Fig. 5A-C; Fig. S3C). The
BM of Bowman’s capsule revealed irregular thickening (Fig. 5A)
and, in some instances, a basket-weave appearance was observed.
Vascular BMs displayed extensive defects, including fragmentation
and focal absence (Fig. 5B), likely causing vascular fragility,
haemorrhage and haematuria, underscoring the vascular component
of Col4a1 renal disease. Analysis of the GBM revealed irregular
thickening, although no interruptions or thinning was observed
(Fig. 5C). The presence of these defects and proteinuria indicates a
role for α1α1α2(IV) in the filtration apparatus. No structural defects
were observed in BM of tubules (Fig. S3C).
To investigate whether the BM defects are the result, at least
in part, of reduced α1α1α2(IV) incorporation, we performed
immunohistochemistry against Col4a1. This revealed a ∼80%
reduction in Col4a1 staining in tubular, mesangial and Bowman’s
capsule BMs (Fig. 5D,E; Fig. S3B). The reduced α1α1α2(IV)
deposition was accompanied by∼40% reduction in perlecan staining
in all major BMs (Fig. 5D,E), but no consistent differences were
observed for laminin or nidogen 1 and 2 (Fig. S5). Interestingly,
∼32% of mutant Bowman’s capsules stained positive for Col4a3,
comparedwith 0% forWT, confirming ectopic deposition ofα3α4α5
(IV) in damagedBMs ofBowman’s capsule (Fig. 5F,G). This ectopic
expression could reflect that mutant parietal epithelial cells express
different collagen networks and/or that these cells have adopted a
more ‘podocyte cell-like’ nature, because Col4a3 is normally
produced by podocytes (Abrahamson et al., 2009). Immunostaining
against podocin (marker for podocytes) detected podocin staining in
Bowman’s capsule of mutant mice, suggesting that at least some
parietal epithelial cells might have undergone cell reprogramming.
Furthermore, a ∼9.8-fold increase in podocin staining was observed
Fig. 3. Erythropoietin treatment of Col4a1 mutant mice. (A) Four-month-old Col4a1+/Svc (black bars) and WT (white bars) mice were treated with Epo,
and haematological analysis was performed before (−Epo) and afer Epo (+Epo) treatment, which showed that treatment rescued haematocrit values in
Col4a1+/Svc mice (WT 44% pretreatment, 44% post-treatment; Col4a1+/Svc 36% pre-treatment, 49% post-treatment; n=4-5). (B) Tail-cuff plethysmography
revealed a rescue of blood pressure in Epo-treated mice (WT 122 mmHg pre-treatment, 114 mmHg post-treatment; Col4a1+/Svc 97 mmHg pre-treatment,
110 mmHg post-treatment; n=4-5). *P<0.05, **P<0.01, ***P<0.001, Student’s unpaired t-test.
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within the glomerulus (Fig. 5F,H). These data indicate that Col4a1
mutations not only affect BM structure but also BM composition.
Chronic ER stress in Col4a1 renal disease
Electron microscopic analysis revealed enlarged ER vesicles
(Fig. 5A; Fig. 6F) in epithelial cells of Bowman’s capsule of
mutant mice, suggestive of ER stress. Activation of ER stress was
confirmed bywestern blotting in kidneys of 3- to 4-month-oldmutant
mice, which had a ∼2.9- and ∼3.6-fold increase in protein levels of
the ER stress markers Bip and Atf4, respectively (Fig. 6A,B).
To shed light on the relative contribution of ER stress and
BM defects to the renal pathology, we investigated the association of
BMdefects and ER stress with the development of renal defects in the
Col4a1+/Raw cohorts used to establish phenotype progression
(Table S3). Western blot analysis against Bip revealed an apparent
transient increase (Fig. 6C) in younger mice, followed by marked
Fig. 4. Analysis of kidney histopathology.
(A) Bowman’s capsule defects in 3- to 4-month-old
Col4a1+/Raw (RAW) and Col4a1+/Svc (SVC) mice
include thickening of the capsule (arrowhead) and
formation of multiple cell layers of parietal
epithelial cells, which can develop a more cuboid
appearance. (B) Haematoxylin and Eosin staining
revealed atrophy of themedulla (indicated by black
box) in 8-month-old Col4a1+/Raw and Col4a1+/Svc
mice that develops in adulthood (see Table S3).
(C) Protein cast (arrowhead) in kidney sections of
Col4a1+/Raw and Col4a1+/Svc mice (n=3, 6 months
old). (D) Perls’ Prussian Blue staining of renal
sections identified haem deposits (arrowhead) in
4-month-old Col4a1+/Svc mice as a sign of
haemorrhage. Perls’ Prussian Blue staining does
not detect intact red blood cells (n=3; scale bars:
20 µm). (E) Semi-quantitative analysis of urine
samples using a dipstick revealed haematuria in
mutant mice. Absence of haematuria was set as a
value of 1 (see Fig. S4C for haematuria scale;
n=6). ***P<0.001.
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Fig. 5. Investigation of mechanisms underlying Col4a1 kidney
disease. (A) Transmission electron microscopic analysis revealed
irregular thickening of the BM of 4-month-old Col4a1+/Svc Bowman’s
capsule (indicated by black arrowhead; white arrowhead indicates
thinner region). The presence of swollen ER vesicles can also be
observed (red arrow). (B) The vascular BM in 4-month-old Col4a1+/Svc
mice (SVC) displayed focal interruptions (right black arrow) and an
irregular less dense appearance with BM fragments (left arrow).
(C) The GBM in 4-month-old Col4a1+/Svc mice showed irregular
thickening (black arrow), but no interruptions were detected. Scale
bars: 2 µm in A-C (n=3). (D) Immunostaining against Col4a1 and
perlecan in 4-month-old Col4a1+/Svc kidney sections followed by
confocal microscopy revealed reduced deposition of Col4a1 and
perlecan in BMs of Col4a1+/Svc mice (n=3). Scale bar: 20 μm.
(E) ImageJ analysis of fluorescence staining in D. (F) Immunostaining
against Col4a3 (green) and podocin (red) revealed deposition in 3- to 4-
month-old mutant BM of Bowmans capsule (white arrows). Scale bar:
20 µm. (G) Fraction of Bowman’s capsules that stain positive (black)
and negative (white) for Col4a3 in WT (0% positive) and Col4a1+/Svc
mice (32% positive; n=85 glomeruli across three animals, Fisher’s
exact test). (H) ImageJ analysis of podocin fluorescence staining in
H revealed ∼9.8-fold increase in SVC. *P<0.05, ***P<0.001, Student’s
unpaired t-test in E,H; Fisher’s exact test in G.
171
RESEARCH ARTICLE Disease Models & Mechanisms (2016) 9, 165-176 doi:10.1242/dmm.021741
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
Fig. 6. ER stress and renal disease. (A) Significantly increased
protein levels of ER stress markers Bip (∼2.9-fold increase) and
Atf4 (∼4.6-fold increase) in 4-month-old Col4a1+/Svc mice (n=3).
Representative band of total protein stain is given as loading control
(entire gel is provided in Fig. S6). (B) Densitometric analysis of Bip
and Atf4 using ImageJ. (C) Examination of protein levels of Bip and
CHOP analysis across Col4a1+/Raw animals of different ages
(40 days, 3-4, 8 and 12 months). Increased protein levels of Bip in
Col4a1+/Raw animals precedes elevated levels of CHOP, which is a
marker for chronic ER-stress-induced apoptosis. Activation of
CHOP coincides with development of atrophy of the medulla (see
Table S3; n=3). (D) Col4a1+/Svc mice display thinning of the BM of
Bowman’s capsule at 40 days of age. Scale bar: 2 μm. (E) Average
BM thickness as measured by ImageJ (WT ∼257 nm; Col4a1+/Svc
∼121 nm; n=3). (F) Distended ER vesicle (black star) in epithelial
cell of Bowman’s capsule in 40-day-old Col4a1+/Svc. Scale bar:
2 μm. (G) Analysis of Bip protein levels in 40-day-old Col4a1+/Svc
mice (n=3). Representative band of total protein stain is given as
loading control (entire gel is provided in Fig. S6). (H) Densitometric
analysis of G. (I) Immunostaining against Bip (red) and Col4a1
(green) on kidneys of 3-month-old mice revealed increased
expression in epithelial cell of Bowman’s capsule (white arrow), and
apparent more intense staining in Col4a1+/Svc. Scale bar: 20 µm
(n=3).
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elevation of CHOP at time points that appear to correspond
to development of medullary atrophy (Fig. 6C). In the UPR,
CHOP is downstream of Bip, reflects progression to chronic
pathogenic ER stress and is associated with ER-associated
apoptosis (Bateman et al., 2009; Ron and Walter, 2007). All 3- to
4-month-old Col4a1+/Raw mice also expressed cleaved caspase 3
(Fig. S6E). Interestingly, although chronic ER stress coincides
with development of medullary atrophy, no significant BM
abnormalities were observed in tubules (Fig. S3), strongly arguing
for a causative role of chronic ER stress in renal tubular disease. By
contrast, the glomerulopathy becomes apparent at 21-40 days of age
and is associated with BM defects but before the onset of the robust
elevation of CHOP levels. Likewise, 40-day-old Col4a1+/Svc kidneys
have a ∼50% reduction in thickness of the BM in Bowman’s capsule
(Fig. 6D,E). Intriguingly, a distended ER could be observed in some
parietal epithelial cells of Bowman’s capsule (Fig. 6F). However,
although this indicates ER retention of collagen IV and suggests ER
stress in some cells, this did not translate into higher ER stress levels
at a tissue level as we failed to detect elevated Bip protein levels
(Fig. 6G). By contrast, significantly elevated Bip levels were detected
in protein homogenates of kidneys at 3-4 months (Fig. 6A,B). This
was confirmed by immunostaining against Bip on kidney sections of
3-month-old mutant mice, which identified Bip expression in the
epithelial cells of Bowman’s capsule (Fig. 6I). In some tubules and
the mesangium, a more punctate intense staining was also observed
(Fig. 6I).
Overall, these data lend support to an adaptive ER stress response
in glomeruli and a chronic pathogenic response in tubules.
Interestingly and importantly, this differential response has also
been observed after pharmacological induction of ER stress (Inagi,
2009). Therefore, our data lend support to a disease mechanismwith
variable relative contributions of ER stress and BM defects,
whereby BM defects play a major role in the glomerulopathy and
ER-stress-induced apoptosis in the tubulopathy.
DISCUSSION
Our analysis of the development and progression of renal disease
caused byCol4a1mutations has expanded the spectrum of potential
clinical defects that can develop in humans with COL4A1mutations
and identified the importance of α1α1α2(IV) in adult kidney
function and pathophysiology. Col4a1 mutations cause a
glomerulopathy and tubulopathy with medullary atrophy, leading
to proteinuria and diabetes insipidus because of a defect in the
ability to concentrate urine. The haematuria attributable to
haemorrhage illustrates an important vascular component to the
renal disease. The progressive nature of the disease argues for
monitoring of renal function with increasing age of patients, thus
impacting patient management.
Col4a1 mouse models led to the identification and
characterization of mutations in humans and thus the description
of clinical phenotypes. Based on this, it is likely that these
phenotypes, including the medullary atrophy, diabetes insipidus,
polyuria and urine-concentrating defect, proteinuria and mild
hypotension, can develop in at least a proportion of these
individuals with COL4A1 mutations. The relative small number
of families described to date, combined with a high level of clinical
heterogeneity between and within families (Kuo et al., 2012;
Vahedi and Alamowitch, 2011) and focus on the cerebrovascular
disease aspects of Col4a1 disease, can all explain why these
phenotypes have yet to emerge and highlight the need for a further
detailed clinical analysis of affected individuals. Our data to date
strongly support a multifactorial origin of the hypotension in
addition to the previously described defects in vascular function
(Van Agtmael et al., 2010). Although our previous data suggested
an association with the reduced blood volume in the presence of
normal plasma volume (Van Agtmael et al., 2010), our Epo
experiments described in this article directly establish this
contribution. It is interesting in this regard that ER stress through
the protein ATF4 can affect Epo production (Chiang et al., 2013).
Moreover, we have identified a blunted response of the distal
tubules to elevated aldosterone levels and increased compensatory
sodium reabsorption in the proximal tubules in response to the
hypotension. Given that the experiments with diuretics were
performed on young animals, before the onset of medullary
atrophy, this indicates a novel role for the basement membrane and
the collagen IV network in the regulation of vascular homeostasis
in distal tubules by being important for the response to aldosterone.
These data show that a compensatory response occurs within the
kidney to the reduced blood pressure by activation of RAAS but
whereby the reduced response to aldosterone renders this
insufficient to normalise blood pressure levels despite increased
sodium reabsorption via proximal tubules. Furthermore, it is likely
that altered vascular resistance is also an underlying factor,
although this remains to be established.
Metabolic cage studies revealed that Col4a1 mutations cause
diabetes insipidus, because mice display the classical signs of
reduced urine osmolality, polyuria and polydipsia. The diabetes
insipidus in 2.5-month-old mice, before the onset of atrophy of the
medulla, and reduced urine concentrating in response to
vasopressin, suggests the development of diabetes insipidus with
a central and nephrogenic origin. The development of chronic ER
stress causing medullary atrophy with inability to elevate Aqp2
protein levels represents a molecular basis for the nephrogenic
diabetes insipidus. The proteinuria is a consistent feature in Col4a1
mutant mice, and our data indicate that this is not confined to the
more severe mutations, such as glycine mutations and deletions
(Favor et al., 2007; Gould et al., 2006). However, the origin of the
proteinuria remains unclear. Although subtle GBM defects are
likely to contribute and indicate the importance of this network for
renal function, it has also been proposed that Bowman’s capsule,
which is severely affected in Col4a1 renal disease, can act as a
secondary barrier (Ohse et al., 2009). In addition, reduced tubular
protein reabsorption (Nielsen and Christensen, 2010) and medullary
atrophy could also contribute to the proteinuria. Although
Bowman’s capsule defects and haematuria are conserved between
our mouse models and HANAC syndrome (Plaisier et al., 2007), we
failed to detect any cyst formation or tubular BM defects. These
phenotypic differences can reflect a separate disease mechanism, as
it has been proposed that HANAC syndrome is caused by a distinct
disease mechanism involving altered integrin signalling (Plaisier
et al., 2010), supported by data published during the revision of the
present paper (Chen et al., 2015). Moreover, our data show that
genetic background also influences the development of Col4a1
renal disease, which has also been observed for albuminuria (Long
et al., 2013; Tsaih et al., 2009).
Many aspects of the pathomolecular mechanisms of COL4A1
defects remain poorly characterised. Our data reveal that Col4a1
mutations not only affect BM structure but that they also alter BM
composition, including reduced incorporation of perlecan. This
indicates that α1α1α2(IV) is required for perlecan deposition in the
BM, which is supported by data fromDrosophila (Pastor-Pareja and
Xu, 2011). The ectopic expression of α3α4α5(IV) in Bowman’s
capsule represents a different mechanism compared with Alport
syndrome, in which absence of α3α4α5(IV) can cause continued
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expression of α1α1α2(IV) in the GBM (Kalluri et al., 1997). To our
knowledge, this is the first evidence of collagen IV network
‘switching’ induced by α1α1α2(IV) defects. The more cuboidal
appearance of the epithelial cells (Fig. 4; also see Van Agtmael
et al., 2005) and podocin expression suggest that this might reflect a
cellular reprogramming, perhaps as a compensatory response. This
is supported by cell reprogramming because of ER stress in
chondrocytes with mutations in Col10a1 (Tsang et al., 2007).
Likewise, our analysis also revealed increased podocin expression
in the glomerulus. Although reduced levels of podocin are well
characterised in kidney disease (Mollet et al., 2009), the
significance of increased expression remains unclear but could
indicate a response to BM defects while also illustrating altered
GBM composition. In conclusion, although their relative
importance to the pathophysiology remains to be determined,
defects in BM composition are part of the response to, and
potentially mechanism of, Col4a1 mutations.
A temporal analysis of ER stress and BM defects revealed that
chronic ER stress appears to coincide with the development of
tubular disease in the absence of BMdefects. By contrast, 40-day-old
animals present with BM defects and glomerulopathy, but much
lower levels of chronic pathogenic ER stress compared with
3-month-old Col4a1+/Raw mice. This provides evidence for the
occurrence of distinct pathomolecular mechanisms reflecting
differences in the relative contribution of ER stress and BM
defects to phenotype development. This has important
consequences for the development of therapeutic avenues, because
ER stress can be caused by mutations in other matrix proteins and be
targeted by small molecules, including chemical chaperones (Engin
and Hotamisligil, 2010; Murray et al., 2014). Rescue of BM defects
and their associated phenotypes might require alternative
approaches, including regeneration of functional intact BMs and
secretion of accurately folded Col4a1. However, it now remains to be
determined whether this disease mechanism applies to all Col4a1
mutations, because disease mechanisms and renal phenotypes might
be mutation dependent (Alamowitch et al., 2009; Kuo et al., 2014;
Plaisier et al., 2010, 2007; Van Agtmael et al., 2005).
In conclusion,Col4a1mutations cause renal disease that involves
cell-specific disease mechanisms, including ER stress and BM
defects. These data will inform the development of therapeutic
strategies for renal diseases resulting from collagen mutations.
MATERIALS AND METHODS
Animal studies
All animal studies were performed in accordance with the UK Home Office
under Project licence 60/4132.
Electron microscopic analysis
Tissue were collected and fixed in 2% glutaraldehyde in phosphate buffer
and processed as previously described (Taylor et al., 2011). EM thickness
was measured using ImageJ (http://imagej.nih.gov/ij/), whereby thickness
was measured on EM images (1900× magnification) using a grid with a
measure being taken every ∼800 nm (total of ∼90 measurements).
Histopathology
Kidneys were fixed in 10% neutral buffered formalin or 4%
paraformaldehyde and embedded in paraffin wax. Sections were stained
with Haematoxylin and Eosin, PicroSirius Red or Perls’ Prussian Blue using
standard protocols.
Systolic blood pressure analysis
Systolic blood pressure was measured using tail-cuff plethysmography as
previously described (Van Agtmael et al., 2010).
In vivo renal function studies
In vivo renal function studies were performed as described by Craigie et al.
(2012). Under anaesthesia, mice were infused intravenously with isotonic
saline at a rate of 200 µl/h/10 g body weight. After a 40 min equilibration
period, mean arterial blood pressure was recorded for 30-40 min and urine
was collected for 1 h. Evans Blue (1 µl/g of a 0.5% solutionw:v) was injected
for measurement of plasma volume; blood volume was calculated from this
and haematocrit. After baseline collections, each mouse received an
intravenous injection of furosemide (3 mg/kg), thiazide (2 mg/kg) or
amiloride (2 mg/kg). The natriuretic response to these agents was assessed
as an index of the in vivo activity of the Na+-K+-2Cl− cotransporter
(NKCC2), the Na+-Cl− cotransporter (NCC) and the epithelial sodium
channel (ENaC), respectively (Bailey et al., 2009; Hunter et al., 2014, 2015).
At the end of the experiment, a 500 µl blood sample was taken for
measurements of plasma sodium and potassium. Sodium and potassium
concentration in urine and plasma was measured by ISE (Roche 9180, UK).
Metabolic cage studies
Animals were individually housed and allowed to acclimatise for 24 h, after
which daily urine samples were collected and water consumption was
measured. Water was withdrawn for 24 h. Vasopressin (Sigma)
administration occurred via intraperitoneal injection, and animals were
subsequently housed in metabolic cages for 6 h. Urine samples were
collected 6 h after intraperitoneal injection and via bladder massage/
vasopressin. Six microlitres of urine was loaded on an SDS-PAGE gel,
followed by silver staining for analysis of proteinuria, whereas ELISA was
used to measure albumin-to-creatinine ratios.
Immunoblotting
Protein extracts were prepared in RIPA buffer containing EDTA protease
(Roche Applied Science) and phosphatase inhibitors (Phostop Roche).
Membranes were blocked with 5% milk or bovine serum albumin before
incubation with primary antibodies BIP (1:10,000; BD Transduction
610979), ATF4 (1:2500; Santa Cruz Sc-200), NHE3 (Stressmarq SPC-
400D; 1:1000), p-NHE3 (Santa Cruz Sc-53961; 1:200), AQP2 (Santa Cruz
Sc-9882; 1:800), NKCC2 (1:1000) and CHOP (Santa Cruz). Membranes
were incubated with horseradish peroxidase-conjugated secondary
antibodies (GE Healthcare) and developed using chemiluminescense
(Millipore). For cleaved caspase 3 (Cell Signaling Technology; 1:1000),
primary and secondary antibodies (LI-COR) were incubated using 50%
Seablock bluffer (ThermoFisher) and 50% tris-buffered saline-0.1% tween
(TBST), and signals were detected using Odyssey Sa imager (LI-COR).
Protein levels were corrected for Coomassie staining of total protein gels run
in parallel with the western blot gels or by total protein stain on the
membrane (Memcode; Pierce). Densitometry was performed using ImageJ
software. Statistical analysis (Graphpad Prism) was done using Student’s
unpaired t-test.
Immunohistochemistry
Immunohistochemistry was performed as described by Taylor et al. (2011).
After fixation in acetone and antigen retrieval, sections were incubated with
primary antibodies [H11 for Col4a1, H22 for Col4a2 and H31 for Col4a3
(all 1:100), perlecan (1:1000), nidogen 1 (1:1000), nidogen 2 (1:1000),
Col1a1 (AbcamAb292; 1:1000), Bip (Abcam; 1:1000) and laminin (Sigma;
1:50)] overnight at 4°C. Incubation with secondary antibodies (1:400;
Jackson ImmunoResearch) was performed and slides were mounted using
Vectashield (Vector). Images were captured using a non-inverted
fluorescent microscope (Zeiss Axioskop-Axiocam) and captured through
AxioVision 4.8 (Zeiss) or as z-stacks using a Zeiss LSM510 Meta confocal
microscope and Zeiss LSM software (Zeiss, Germany), which was also used
for generating projections. ImageJ analysis was used for quantification of
fluorescence as previously described (Murray et al., 2014).
Haematological analysis
Epo was administered via intraperitoneal injection of 150 units (three times
per week) of human recombinant erythropoietin (gift fromDr JoMountford,
University of Glasgow).
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Statistical analysis
Statistical analysis (Graphpad Prism) was done by Student’s unpaired t-test
and byANOVA and Bonferroni post hoc test for in vivo renal function assays.
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